This application claims priority under 35 U.S.C. §119 to Japanese Patent Application No. JP2007-143435 filed May 30, 2007 and Japanese Patent Application No. JP2007-170008 filed Jun. 28, 2007, the entire content of which is hereby incorporated by reference.
The present invention relates to a sample analyzer for analyzing a sample containing particles such as blood cells and urine cells, a blood analyzer for analyzing blood, and a method of displaying a particle distribution map representing a distribution state of the particles contained in the sample.
An analyzer for analyzing a sample containing particles is conventionally known. For example, U.S. Patent Application Publication No. 2006-004530 discloses a specimen analyzer for electrically or optically detecting each particle such as red blood cell and white blood cell in a blood sample, and creating a one-dimensional frequency distribution map (histogram) or a two-dimensional scattergram using characteristic parameter information representing characteristics of each particle.
The specimen analyzer disclosed in U.S. Patent Application Publication No. 2006-004530 includes a display, where an analysis result display screen for displaying the analysis result of the blood sample is displayed on the display, as shown in FIG. 9 of the document. The number of particles, such as red blood cells contained in the measured blood sample, and the particle distribution map (histogram or scattergram) created in the above manner are shown on the analysis result display screen. When such analysis result display screen is displayed, the user can know about the number of particles such as the red blood cells contained in the measured blood sample, and can visually recognize the distribution state of the particles in the particle distribution map.
However, it is not easy for the user to look at the distribution state of the particles in the particle distribution map and evaluate whether such distribution state is abnormal or normal. Therefore, a reference particle distribution map which becomes an index for making an evaluation on the distribution state is desired to be displayed on the display.
In order to respond to such demand, a particle distribution map representing the distribution state of particles contained in the blood sample taken from a healthy subject may be displayed as the reference particle distribution map next to the particle distribution map of the measured sample. However, since the display area in the analysis result display screen as shown in FIG. 9 of U.S. Patent Application Publication No. 2006-004530 is limited, the display area for displaying information other than the particle distribution map becomes small if such method is used. If the display of each particle distribution map arranged side by side is reduced to ensure the display area for displaying information other than the particle distribution map, the distribution state of the particles in the particle distribution map becomes difficult to visually recognize.
Furthermore, U.S. Pat. No. 6,246,786 discloses a blood analyzer for storing region patterns in which a region where specific particles such as “lymph cells” and “monocytes” appear is surrounded by a region line for the normal blood sample in advance in a memory in correspondence to the coordinate system of the distribution map, and displaying the same on the display with the distribution map of the measured blood sample in order to facilitate the user evaluating whether the measured blood sample is normal or abnormal. According to such display, the user can visually recognize whether or not the lymph cells or the monocytes in the measured blood sample appear within the region pattern in the normal blood sample.
In recent years, analysis of blood samples of animals other than human being is being carried out in veterinary hospitals, livestock experimental station, and the like. In the case of human being, blood test is widely carried out as one item of health examination and great amount of normal blood cell distribution maps and abnormal blood cell distribution maps are stored as analysis data of the blood sample, whereas in the case of animals, the analysis data of the blood sample may not be stored or analyzed depending on the species. The evaluation of one analysis data may differ depending on the species of animals.
Therefore, when analyzing blood samples of animals other than human being, it is difficult to create in advance the region patterns for the normal blood sample, and displaying the region pattern along with the distribution map of the measured blood sample as in the analyzer disclosed in U.S. Pat. No. 6,246,786.
However, in the case of analyzing the blood sample of animals other than human being, it is desired that the user can easily make an evaluation on whether the blood sample is normal or abnormal by looking at the distribution map of the measured blood sample.
A first aspect of the present invention is a sample analyzer for analyzing a sample containing particles, comprising: a display; a measurement section for measuring a sample containing particles; and a controller in communication with the display and the measurement section, the controller being configured to 1) generate a particle distribution map representing a distribution of the particles contained in the sample, based on measurement data obtained by the measurement section; and 2) control the display so as to display the particle distribution map of the sample at a predetermined display position and to display a reference particle distribution map at the predetermined display position so as to be visually compared with the particle distribution map of the sample.
A second aspect of the present invention is a sample analyzer for analyzing a sample containing particles, comprising: a display; a measurement section for measuring a sample containing particles; generating means for generating a particle distribution map representing a distribution of the particles contained in the sample, based on measurement data obtained by the measurement section; and display controlling means for controlling the display so as to display the particle distribution map of the sample at a predetermined display position and to display a reference particle distribution map at the predetermined display position so as to be visually compared with the particle distribution map of the sample.
A third aspect of the present invention is a method for displaying a particle distribution map representing a distribution of particles contained in a sample, comprising steps of: (a) generating a particle distribution map representing a distribution of particles contained in a sample by measuring the sample containing the particles and displaying the particle distribution map at a predetermined display position; and (b) displaying a reference particle distribution map at the predetermined display position so as to be visually compared with the particle distribution map of the sample.
A fourth aspect of the present invention is a blood analyzer for analyzing blood samples of a plurality of species of animals, comprising: a display; a measurement section for measuring a blood sample; and a controller in communication with the display and the measurement section, the controller being configured to 1) accept a selection of an animal species to be measured; 2) generate a blood cell distribution map representing a distribution of blood cells contained in the blood sample, based on measurement data obtained by the measurement section; and 3) control the display so as to display the blood cell distribution map of the blood sample and a reference blood cell distribution map corresponding to the selected animal species so as to be visually compared.
A fifth aspect of the present invention is a blood analyzer for analyzing blood samples of a plurality of species of animals, comprising: a display; a measurement section for measuring a blood sample; and accepting means for accepting a selection of an animal species to be measured; generating means for generating a blood cell distribution map representing a distribution of blood cells contained in the blood sample, based on measurement data obtained by the measurement section; and display controlling means for controlling the display so as to display the blood cell distribution map of the blood sample and a reference blood cell distribution map corresponding to the selected animal species so as to be visually compared.
A sixth aspect of the present invention is a method for displaying a blood cell distribution map in a blood analyzer for analyzing blood samples of a plurality of species of animals, comprising steps of: a) selecting an animal species to be measured; b) generating a blood cell distribution map representing a distribution of the blood cells contained in the blood sample by measuring the blood sample; and c) displaying the generated blood cell distribution map and a reference blood cell distribution map corresponding to the animal species selected in step a) so as to be visually compared.
The embodiment of the present invention will now be described with reference to the drawings.
[Overall Configuration]
A blood analyzer 1 according to the present embodiment is an analyzer for analyzing the blood of an animal other than a human such as dogs, cats, cows, and horses. As shown in
[Measurement Unit]
As shown in
As shown in
As shown in
[Sample Preparing Section]
As shown in
[WBC Detecting Section]
The WBC detecting section 5 is an optical flow cytometer capable of measuring the white blood cells through a flow cytometry method by a semiconductor laser. The WBC detecting section 5 includes a flow cell 51 forming a liquid current of the measurement sample. As shown in
As shown in
When the measurement reagent flows to the flow cell 51, optical signals of scattered light and fluorescent light generate by the laser light. The forward signal lights are irradiated towards the photodiode 54. Among the lights advancing along the optical axis linearly extending from the semiconductor laser light source 52, the direct light of the semiconductor laser light source 52 is shielded by the beam stopper 54a, and substantially only the scattered light (hereinafter referred to as forward scattered light) advancing along the optical axis direction enter the photodiode 54. The forward scattered light emitted from the flow cell 51 is photoelectric converted by the photodiode 54, and the electric signal generated therefrom (hereinafter referred to as forward scattered optical signal) is amplified by an amplifier 54b and output to the controller 8. Such forward scattered optical signal reflects the size the blood cells, and the size etc. of the blood cell can be obtained when the forward scattered optical signal is signal processed by the controller 8.
A side light collecting lens 55 is arranged on the side of the flow cell 51 in a direction orthogonal to the optical axis linearly extending from the semiconductor laser light source 52 to the photodiode 54, so that the side light (light emitted in a direction intersecting the optical axis) generated when the semiconductor laser is irradiated on the blood cell passing through the flow cell 51 is collected by the side light collecting lens 55. A dichroic mirror 56 is arranged on the downstream side of the side light collecting lens 55, where the signal light sent from the side light collecting lens 55 is divided into the scattered light component and the fluorescent light component by the dichroic mirror 56. A photodiode 57 for side scattered light reception is arranged on the side of the dichroic mirror 56 (direction intersecting the optical axis direction connecting the side light collecting lens 55 and the dichroic mirror 56), and an optical filter 58a and an avalanche photodiode 58 are arranged on the downstream side of the optical axis of the dichroic mirror 56. The side scattered light component divided by the dichroic mirror 56 is photoelectric converted by the photodiode 57, and the electric signal generated therefrom (hereinafter referred to as side scattered optical signal) is amplified by an amplifier 57a, and output to the controller 8. The side scattered optical signal reflects internal information of the blood cell (size of core, and the like), and the size of the core etc. of the blood cell can be obtained when the side scattered optical signal is signal processed by the controller 8. Furthermore, the side fluorescent light component generated from the dichroic mirror 56 is wavelength selected by the optical filter 58a, and thereafter, photoelectric converted by the avalanche photodiode 58, and the electric signal generated therefrom (hereinafter referred to as side fluorescent optical signal) is amplified by an amplifier 58b, and output to the controller 8. The side fluorescent optical signal reflects information related to the stain degree of the blood cell, and the stainability etc. of the blood cell can be obtained when the side fluorescent optical signal is signal processed by the controller 8.
[RBC/PLT Detecting Section]
The RBC/PLT detecting section 6 can measure the number of red blood cells and the number of blood platelets through sheath flow DC detection method. The RBC detecting section 6 includes a flow cell (not shown), where the measurement sample is supplied from the chamber 22 to such flow cell. When measuring the red blood cells and the blood platelets, the diluting solution is mixed with blood in the chamber 22 to prepare the measurement sample. Such measurement sample is supplied to the flow cell from the sample preparing section 4 along with sheath liquid, so that liquid current in which the measurement sample is surrounded by sheath liquid forms in the flow cell. An aperture having an electrode is arranged in the middle of the flow channel in the flow cell, which aperture detects the DC resistance in the aperture when the blood cell in the measurement sample passes through the relevant aperture one at a time, and outputs the electric signal to the controller 8. The DC resistance increases when the blood cell passes through the aperture, and thus the electric signal reflects the pass-through information of the blood cell in the aperture, and the red blood cells and the blood platelets can be counted by signal processing the electric signal.
Discrimination of the red blood cells and the blood platelets can be satisfactorily performed using the RBC/PLT detecting section 6 or an electrical detecting section when measuring the blood of a human, but discrimination of the red blood cells and the blood platelets may not be satisfactorily performed with only the RBC/PLT detecting section 6 in the case of measuring the blood of an animal. Thus, the blood analyzer 1 of the present embodiment is configured to measure the measurement sample for the red blood cell and the blood platelet measurement with both the RBC/PLT detecting section 6 of the electrical detecting section and the WBC detecting section 5 or the optical detecting section.
[HGB Detecting Section]
The HGB detecting section 7 can measure the hemoglobin content through the SLS hemoglobin method. A cell for containing the diluted sample is arranged in the HGB detecting section 7, and the sample from the chamber 22 is supplied to the cell. When measuring hemoglobin, the diluting solution and the hemolytic agent are mixed with blood in the chamber 22 to prepare the measurement sample. The hemolytic agent has a property of transforming hemoglobin in the blood to SLS-hemoglobin. The light emitting diode and the photodiode are arranged facing each other with the cell in between, so that the light from the light emitting diode is received by the photodiode. The light emitting diode emits light of a wavelength having high absorption by the SLS-hemoglobin, and the cell is made of plastic material having high translucency. Thus, the transmitted light in which the emitted light of the light emitting diode is more or less absorbed only by the measurement sample is received by the photodiode. The photodiode outputs an electric signal corresponding to the light received amount (absorption) to the controller 8, and the controller 8 compares such absorption and the absorption of only the diluting solution measured in advance and calculates a hemoglobin value.
The controller 8 thus receives the electric signals from the WBC detecting section 5, the RBC/PLT detecting section 6, and the HGB detecting section 7, and transmits measurement data representing the size of the blood cell, the size of the core of the blood cell, the stainability of the blood cell, the number of red blood cells, the number of blood platelets, the hemoglobin value, and the like to the data processing unit 3 via the communicating section 9.
[Data Processing Unit]
As shown in
The CPU 301a executes computer programs stored in the ROM 301b and the computer programs loaded in the RAM 301c. The computer serves as the data processing unit 3 when the CPU 301a executes the application program 305a, as hereinafter described.
The ROM 301b is configured by mask ROM, PROM, EPROM, EEPROM, and the like, and is recorded with computer programs to be executed by the CPU 301a, data used for the same, and the like.
The RAM 301c is configured by SRAM, DRAM, and the like. The RAM 301c is used to read out the computer programs recorded on the ROM 301b and the hard disc 301d. The RAM 301c is used as a work region of the CPU 301a when executing the computer programs.
The hard disc 301d is installed with various computer programs to be executed by the CPU 301a such as operating system and application program, as well as data used in executing the computer program. The application program 305a to be hereinafter described is also installed in the hard disc 301d.
The read-out device 301e is configured by flexible disc drive, CD-ROM drive, DVD-ROM drive, and the like, and is able to read out computer programs and data recorded on a portable recording medium 305. The application program 305a for causing the computer to realize a predetermined function is stored in the portable recording medium 305, where the computer serving as the data processing unit 3 reads out the application program 305a from the portable recording medium 305, and installs the application program 305a to the hard disc 301d.
The application program 305a is not only provided by the portable recording medium 305, but also provided through communication line (wired or wireless) from external devices communicatably connected with the data processing unit 3 through the communication line. For instance, the application program 305a may be stored in the hard disc of the server computer on the Internet, so that the data processing unit 3 can access the server computer to download the computer program and install the computer program to the hard disc 301d.
Operating system providing graphical user interface environment such as Windows (registered trademark) manufactured and sold by US Microsoft Co. is installed in the hard disc 301d. The application program 305a according to the present embodiment is assumed to operate on the operating system.
The input/output interface 301f is configured by serial interface such as USB, IEEE1394, RS-232C; parallel interface such as SCSI, IDE, IEEE1284; analog interface such as D/A converter, A/D converter, and the like. The input device 303 including a keyboard and a mouse is connected to the input/output interface 301f, so that the user can input data to the data processing unit 3 using the input device 303.
The image output interface 301h is connected to the display 302 configured by LCD, CRT, or the like, and is configured to output an image signal corresponding to the image data provided from the CPU 301a to the display 302. The display 302 displays the image (screen) according to the input image signal.
The communication interface 301g is, for example, Ethernet (registered trademark) interface. The data processing unit 3 transmits and receives data with the measurement unit 2 using a predetermined communication protocol by means of the communication interface 301g.
The data processing unit 3 executes the application program 305a on the CPU 301a to process the measurement data received from the measurement unit 2, and calculate the number if white blood cells (WBC), the number of red blood cells (RBC), the hemoglobin content (HGB), the hematocrit value (HCT), the average red blood cell volume (MCV), the average red blood cell hemoglobin content (MCH), the average red blood cell hemoglobin concentration (MCHC), the number of blood platelets (PLT), and the like. The data processing unit 3 can create various two-dimensional scattergrams a histograms (one-dimensional frequency distribution map) using the measurement data received from the measurement unit 2.
The data processing unit 3 can stored in advance in the hard disc 301d a plurality of reference particle distribution maps (reference scattergrams and histograms) corresponding to the animal species to be analyzed by the blood analyzer 1. The reference particle distribution map is a particle distribution map displayed on the display 302 to be compared with the particle distribution map of the measured specimen, and serves as an index for determining whether the measured specimen is normal or abnormal.
The user of the blood analyzer 1 inputs the animal species of the specimen measured by the measurement unit 2 using the input device 303 of the data processing unit 3. The data processing unit 3 has a function of displaying a screen for the user to select the animal species (e.g., dog, cat, horse, and the like) on the display 302, and a function of accepting the input signal for selecting the animal species from the input device 303 such as keyboard and mouse.
[Processes by Measurement Unit and Data Processing Unit]
The flow of process in the measurement unit 2 and the data processing unit 3 will now be described using
The CPU 301a of the data processing unit 3 then determines whether or not a display instruction of a manual dialogue is made (step S3-3). Specifically, the CPU 301a determines whether or not “manual” button T1 arranged in the tool bar T of the menu screen shown in
After displaying the manual dialogue shown in
The controller 8 of the measurement unit 2 determines whether or not a measurement start button (not shown) arranged in the measurement unit 2 is pushed (step S2-2).
If the measurement start button is pushed, the controller 8 causes the sample preparing section 4 to prepare the measurement sample for red blood cell and blood platelet measurement (hereinafter referred to as “RBC/PLT measurement sample”), the measurement sample for white blood cell measurement (hereinafter referred to as “WBC measurement sample”), and the measurement sample for hemoglobin measurement (hereinafter referred to as “HGB measurement sample”) (step S203). If the measurement start button is not pushed, the controller 8 proceeds to the process of step S206.
The measurement unit 2 then performs the measurement of the RBC/PLT measurement sample, the measurement of the WBC measurement sample, and the measurement of the HGB measurement sample (step S2-4). In the present embodiment, one part of the RBC/PLT measurement sample is measured in the RBC/PLT detecting section 6, and other parts of the RBC/PLT measurement sample are measured in the WBC detecting section 5. The WBC measurement sample is measured in the WBC detecting section 5, and the HGB measurement sample is measured in the HGB detecting section 7.
The controller 8 of the measurement unit 2 transmits the measurement data to the CPU 301a through the communicating section 9 and the communication interface 301g of the data processing unit 3 (step S2-5).
The CPU 301a of the data processing unit 3 determines whether or not the measurement data is received from the controller 8 of the measurement unit 2 (step S3-6), and executes a classifying/counting process of the particles contained in the measurement sample based on the measurement data if the measurement data is received (step S3-7). If the measurement data is not received, the CPU 301a proceeds to the process of step S3-12.
In the classifying/counting process of the particles, the CPU 301a of the data processing unit 3 creates a histogram shown in
In the blood analyzer 1 according to the present embodiment, the RBC/PLT measurement sample is not only measured in the RBC/PLT detecting section 6 or the electrical detecting section but is also measured in the WBC detecting section 5 or the optical detecting section. The CPU 301a of the data processing unit 3 creates a scattergram shown in
The CPU 301a of the data processing unit 3 creates a two-dimensional scattergram shown in
The CPU 301a stores the analysis result acquired in the above manner in the hard disc 301d (step S308).
The CPU 301a then displays the analysis result stored in the hard disc 301d through the image output interface 301h (step S309). The display process of the analysis result by the CPU 301a will now be described with reference to
First, the CPU 301a reads out the analysis result stored in the hard disc 301d to the RAM 301c, and displays an analysis result screen shown in
The CPU 301a then determines whether or not right-click is made on one of the particle distribution maps of the distribution map display region V2 (step S902), and displays the right-click menu on the display 302 as shown in FIG. 20 through the image output interface 301h if right-click is made on one of the particle distribution maps (step S903). If right-click is not made on either of the particle distribution maps, the CPU 301a proceeds to the process of step S913. Information indicating on which particle distribution map the right-click was made is stored in the RAM 301c. A case where the right-click is made on the DIFF scattergram of the distribution map region V2 will be described below.
After displaying the right-click menu in the process of step S903, the CPU 301a determines whether or not “reference particle distribution map” command arranged on the right-click menu is clicked (S904), where if the “reference particle distribution map” command is clicked, a hierarchical menu arranged with “display” command and “change setting” command is displayed on the display 302 through the image output interface 301h (step S905), as shown in
After displaying the hierarchical menu shown in
If the “change setting” command is clicked in step S906, the CPU 301a displays a display setting dialogue shown in
After displaying the display setting dialogue in step S909, the CPU 301a determines whether or not change instruction of the display setting of the reference particle distribution map is accepted in the display setting dialogue (step S910), and changes the display setting of the reference particle distribution map when the change instruction of the display setting is accepted (step S911). If the change of the display setting is not accepted, the CPU 301a proceeds to the process of step S913.
After changing the display setting of the reference particle distribution map in step S911, the CPU 301a reads out the reference particle distribution map from the hard disc 301d based on the changed display setting (step S912), and displays the read-out reference particle distribution map on the display 302 (step S908).
In this case, if “switch” is set as the displaying method of the reference particle distribution map, the DIFF scattergram of the measured specimen and the reference DIFF scattergram are automatically alternately switched and displayed (view displayed with “Ref.” character is reference DIFF scattergram) for every predetermined time (about every one second in the present embodiment), as shown in
A case in which “change transparency” and “overlap” is set for the displaying method of the reference particle distribution map will now be described. For the sake of convenience of the explanation, a case of displaying the reference particle distribution map corresponding to the RBC histogram of the blood of the cat will be described herein.
If “change transparency” is set for the displaying method of the reference particle distribution map, the RBC histogram of the measured specimen and the reference RBC histogram (denoted with “Ref.” character) are overlapped and displayed, and the control bar 42 is displayed on the right side, as shown in
If “overlap” is set for the displaying method of the reference particle distribution map, the RBC histogram of the measured specimen and the reference RBC histogram are overlapped and displayed, as shown in
After displaying the reference particle distribution map in step S908, the CPU 301a determines whether or not the registration instruction of the reference particle distribution map is made (step S913). Specifically, as shown in
If the registration instruction of the reference particle distribution map is made, the CPU 301a executes the registration process of the reference particle distribution map (step S914). In the registration process of step S914, the CPU 301a stores the PLT-O scattergram displayed on the distribution map display region V2 of the analysis result screen in the hard disc 301d as the reference particle distribution map corresponding to the PLT-O scattergram of the blood of the cat. In this case, “Ref. K”, “Ref. 6” and the like are input as the file name corresponding to the particle distribution map to be stored, and the file name, the measurement date and time, and the specimen number are stored in the hard disc 301d in correspondence to the data of the particle distribution map along with the data of the particle distribution map. After the registration process of the reference particle distribution map is terminated, the CPU 301a returns the process.
The CPU 301a then determines whether or not instruction is made to display on the display 302 for the specimen (stored specimen) which analysis is completed in the past and the analysis result is stored in the hard disc 301d (step S3-10). Specifically, the CPU 301a determines whether or not “explorer” button T2 (see
The display process of the stored specimen in step S3-11 will be described with reference to
The CPU 301a then determines whether or not selection of a specimen is accepted from the list displayed on the explorer screen (step S112). Specifically, if one of the specimens in the list is double clicked or if one of the specimens is selected by clicking and the “browser” button T3 (see
If the selection of the specimen is accepted in step S112, the CPU 301a reads out the analysis result of the selected specimen from the hard disc 301d to the RAM 301c (step S113), and displays the read-out analysis result on the display 302 through the image output interface 301h (step S114). One example thereof is shown in
After the analysis result of the stored specimen is displayed on the display 302 in step S14, the CPU 301a determines whether or not registration instruction of the reference particle distribution map is made (step S115), and registers the particle distribution map displayed in the distribution map display region V2 as the reference particle distribution map if the registration instruction of the reference particle distribution map is made (step S116). The processes of step S115 and step S116 are the same as the processes of step S913 and step S914 described above, and thus the description thereof will be omitted. After the process in step S116 is terminated, the CPU 301a returns the process. Thus, in the present embodiment, the particle distribution map of the specimen which analysis is completed in the past can be registered as the reference particle distribution map of another specimen. Therefore, various particle distribution maps can be registered as the reference particle distribution map according to the need of the user.
The CPU 301a then determines whether or not a shutdown instruction is made by the user, specifically, whether or not “shutdown” icon S of the menu screen (see
If the shutdown instruction is not made by the user, the CPU 301a returns to the process of step S3-3.
The controller 8 of the measurement unit 2 determines whether or not the shutdown signal is received from the CPU 301a of the data processing unit 3 (step S2-6), and executes the shutdown of the measurement unit 2 if the shutdown signal is received (step S2-7). The controller 8 returns to the process of step S2-2 if the shutdown signal is not received from the CPU 301a.
Therefore, according to the blood analyzer 1 of the present embodiment, the particle distribution map of the measured blood sample and the reference particle distribution map can be displayed so as to be compared without reducing the display area for displaying the analysis result information other than the particle distribution map.
According to the blood analyzer 1 of the present embodiment, the particle distribution map of the blood collected from a healthy subject may be displayed as the reference particle distribution map, or the particle distribution map of the blood collected from a subject having a predefined illness may be displayed. Thus, evaluation on whether or not the measured blood is collected from a health subject, evaluation on whether or not the measured blood is collected from a subject having a predefined illness, and the like can be easily made with reference to the displayed reference particle distribution map.
According to the blood analyzer 1 of the present embodiment, the particle distribution map of the specimen measured in the past can be freely registered as the reference particle distribution map. Therefore, if for example, the particle distribution map of the blood of the subjected measured one week before is registered as the reference particle distribution map, the particle distribution map obtained one week before can be displayed as the reference particle distribution map when measuring the blood collected from the same subject one week after and displaying the analysis result thereof. Thus, temporal change in the analysis result of the blood of the same subject can be checked.
According to the blood analyzer 1 of the present embodiment, the reference particle distribution map can be displayed for comparison with the particle distribution map of the measured blood even when analyzing blood of an animal species other than human being. Thus, even when measuring the blood of the animal species other than human being, the user can easily make an evaluation on whether or not the relevant blood is normal or abnormal, and the like by simply looking at the particle distribution map of the measured blood once.
In the above embodiment, an example of a blood analyzer for analyzing the blood of animals other than human being such as dogs and cats has been described by way of example, but the present invention is not limited thereto, and may applied to a blood analyzer for analyzing the blood of a human.
Furthermore, in the present embodiment, an example of a blood analyzer for analyzing the blood sample has been described, but the present invention is not limited thereto, and may be applied to a sample analyzer for analyzing a sample including biological particles such as urine cells other than the blood cells, fine ceramics particles, pigments, powder particles such as cosmetic powder, and the like.
In the present embodiment, the two-dimensional scattergram drawn using the side scattered light intensity in the X-axis direction and the side fluorescent light intensity or the forward scattered light intensity in the Y-axis direction is displayed, but the present invention is not limited thereto, and a three-dimensional scattergram taking the number of blood cells in the Z-axis direction may be displayed.
In the present embodiment, an example in which the display setting of the reference particle distribution map is made as a default, and the display setting of the reference particle distribution map by default is changed in the display setting dialogue displayed when right clicked on the particle distribution map of the analysis result screen is described, but the present invention is not limited thereto, and an operation of changing the display setting of the reference particle distribution map may be performed by clicking the “setting (S)” button arranged on the menu bar 40 of the analysis result screen.
In the present embodiment, an example in which the reference particle distribution map is displayed by the display setting of default of before change is made by the user in the next display process even if the display setting of the reference particle distribution map by default is changed by the user in the display setting dialogue is described, but the present inventions is not limited thereto, and the display of the reference particle distribution map may be carried out based on the display setting changed by the user even in the next display process when the display setting of the reference particle distribution map by default is changed by the user in the display setting dialogue.
In the present embodiment, the reference particle distribution map to be displayed on the display 302 and the displaying method thereof are set in advance at default, but the present invention is not limited thereto, and only the reference particle distribution map to be displayed on the display 302 may be set at default, and the displaying method may be set by the user every time the reference particle distribution map is displayed.
In the present embodiment, an example in which the reference particle distribution map is displayed on the display 302 based on the display setting by default if the display setting of the reference particle distribution map is not changed in the display setting dialogue is described, but the display setting by default may be customized by the user.
In the present embodiment, the change of the switching speed of the particle distribution map cannot be made when the displaying method of the reference particle distribution map is set to “switch”, but the data processing unit 3 may be configured such that the switch speed of the particle distribution map can be changed. According to such configuration, the convenience of the user can be enhanced.
In the present embodiment, the switching operation of the particle distribution map is automatically performed when the displaying method of the reference particle distribution map is set to “switch”, but the present invention is not limited thereto, and the switching operation of the particle distribution map may be made every time the user double clicks on the particle distribution map.
In the present embodiment, the particle distribution map of the measured specimen and one reference particle distribution map are alternately switched and displayed when the displaying method of the reference particle distribution map is set to “switch”, but the present invention is not limited thereto, and the priority may be set from first to fifth, for example as the reference particle distribution map displayed on the display 302 of the reference particle distribution map stored in the hard disc 301d, and the first to the fifth reference particle distribution map may be sequentially and automatically switched and displayed. The first to the fifth reference particle distribution map may be sequentially switched and displayed every time the user double clicks on the particle distribution map.
In the present embodiment, two particle distribution maps are alternately switched and displayed by displaying the reference particle distribution map on the screen at the same time as when the particle distribution map of the measured blood sample disappears from the screen, but the present invention is not limited thereto, and display may be made such that the particle distribution map of the measured blood sample gradually switches to the reference particle distribution map using the morphing technique (technique of expressing a picture such that a certain image smoothly deforms into another image). In this case, the deformation of the particle distribution map by the morphing technique may be automatically carried out, or a control bar may be arranged and the particle distribution map may be deformed by having the user drag the handle of the control bar.
In the present embodiment, two particle distribution maps are alternately switched and displayed by displaying the reference particle distribution map on the screen at the same time as when the particle distribution map of the measured blood sample disappears from the screen, but the present invention is not limited thereto, and display may be made such that the reference particle distribution map gradually appears on the screen as the particle distribution map of the measured blood sample gradually disappears from the screen, and the particle distribution map of the measured blood sample gradually appears on the screen as the reference particle distribution map gradually disappears from the screen. Such switching may be automatically carried out, or a control bar may be arranged so that switching is carried out by having the user drag the handle of the control bar.
In the present embodiment, the RBC histogram and the DIFF scattergram are displayed on the distribution map display region V2 of the analysis result screen shown in
Furthermore, in the present embodiment, when the displaying method of the reference histogram is set to “change transparency”, the transparency of the distribution curve of the reference histogram is changed by having the user drag the handle of the control bar, but the present invention is not limited thereto, and the transparency of the distribution curve may be automatically changed.
In the present embodiment, when the displaying method of the reference histogram is set as “change transparency”, the transparency of the distribution curve of the reference histogram is changed, but the transparency of the distribution curve of the histogram of the measured blood sample may be changed. If the transparency of the distribution curve of the histogram of the measured blood sample becomes high, the transparency of the distribution curve of the reference histogram accordingly becomes lower, and if the transparency of the distribution curve of the measured blood sample becomes lower, the transparency of the distribution curve of the reference histogram accordingly becomes higher.
In the present embodiment, the reference histogram is displayed by “change transparency”, but the not limited to the histogram, and the reference scattergram may be displayed by “change transparency”.
In the present embodiment, the distribution curves of the two histograms are drawn with lines of the same thickness when displaying the histogram of the measured blood sample and the reference histogram in an overlapping manner, but the distribution curve in the histogram of the measured blood sample may be drawn thicker than the distribution curve of the reference histogram, as shown in
In the present embodiment, an example in which the reference particle distribution map is stored in the hard disc 301d of the data processing unit 3 by executing the registration process of the reference particle distribution map in step S914 of
In the present embodiment, the PLT-O scattergram obtained by measuring the blood of the cat is registered as the reference particle distribution map corresponding to the PLT-O scattergram of the blood of the cat in the registration process of the reference particle distribution map in step S914 of
In the present embodiment, the reference particle distribution map stored in the hard disc 301d of the data processing unit 3 is displayed on the display 302, but the present invention is not limited thereto, and the reference particle distribution map may be read out from a portable recording medium such as CD-ROM storing the reference particle distribution map by means of the readout device 301e, and the read-out reference particle distribution map may be displayed on the display 302 without being stored in the hard disc 301d. The reference particle distribution map may be displayed on the display 302 through the communication network from an external equipment communicably connected to the data processing unit 3 through the communication network such as LAN or Internet.
In the present embodiment, the blood analyzer 1 is configured by the measurement unit 2 and the data processing unit 3, which is a separate body from the measurement unit 2, but may have the functions of both the measurement unit 2 and the data processing unit 3 loaded in a single device.
In the present embodiment, the input of the specimen number/selection of animal species are carried out using the mouse, the keyboard, and the like by the user on the screen displayed on the display 302 before the measurement of the specimen is started, but a barcode recorded with the animal species and the specimen number may be attached to the blood collecting tube, and the blood analyzer may be configured to read the barcode attached to the blood collecting tube with the barcode reader before measurement is started, for example.
In the present embodiment, the input of the specimen number/selection of animal species are carried out before the measurement of the specimen is started, but the present invention is not limited thereto, and the input of the specimen number/selection of animal species may be again carried out after the data processing of the measurement data is performed if the user makes an erroneous selection of the animal species. In this case, the data process of the measurement data is again performed preferably with the analysis condition corresponding to the subsequently selected animal species.
In the present embodiment, the particle distribution map of the measured blood sample and the reference particle distribution map are alternately switched and displayed in the same display region, but the particle distribution map of the measured blood sample and the reference particle distribution map may be displayed side by side. In such displaying method as well, the user can easily make an evaluation of whether or not the blood sample is normal or abnormal by simply looking at the particle distribution map of the measured blood sample once.
In the present embodiment, the particle distribution map having a horizontal axis and a vertical axis is used as the reference particle distribution map, but only the portion excluding the horizontal axis and the vertical axis may be used as the reference particle distribution map. Thus, when alternately switching the particle distribution map of the measured blood sample and the reference particle distribution map, the horizontal axis and the vertical axis are displayed on the screen and only the portion excluding the horizontal axis and the vertical axis may be alternately switched. When gradually deforming the particle distribution map of the measured blood sample to the reference particle distribution map using the morphing technique and the like, the horizontal axis and the vertical axis may be displayed on the screen, and only the portion excluding the horizontal axis and the vertical axis may be deformed.
Number | Date | Country | Kind |
---|---|---|---|
2007-143435 | May 2007 | JP | national |
2007-170008 | Jun 2007 | JP | national |
Number | Name | Date | Kind |
---|---|---|---|
5541064 | Bacus et al. | Jul 1996 | A |
6246786 | Nishikiori et al. | Jun 2001 | B1 |
6391263 | Mishima et al. | May 2002 | B1 |
7996188 | Olson et al. | Aug 2011 | B2 |
8017078 | Linssen et al. | Sep 2011 | B2 |
20010037366 | Webb et al. | Nov 2001 | A1 |
20020022772 | Dodds | Feb 2002 | A1 |
20040254479 | Fralick et al. | Dec 2004 | A1 |
20060004530 | Miyamoto et al. | Jan 2006 | A1 |
20060111634 | Wu | May 2006 | A1 |
20060209061 | Burch et al. | Sep 2006 | A1 |
20070179715 | Ariyoshi | Aug 2007 | A1 |
20070247463 | Qian et al. | Oct 2007 | A1 |
20090317860 | Kawate | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
1880942 | Dec 2006 | CN |
1033573 | Sep 2000 | EP |
10-019761 | Jan 1998 | JP |
10-090156 | Apr 1998 | JP |
2000-310642 | Nov 2000 | JP |
2005-537781 | Dec 2005 | JP |
2006-234829 | Sep 2006 | JP |
2007-078508 | Mar 2007 | JP |
2009-534663 | Sep 2009 | JP |
WO 03069421 | Aug 2003 | WO |
Entry |
---|
Office Action from counterpart Chinese Application No. 200810111351.4, dated Oct. 12, 2010, 4 pages. |
Number | Date | Country | |
---|---|---|---|
20090006003 A1 | Jan 2009 | US |